Article
Cancer genomics: why rare is valuable.
Journal of molecular medicine (Berlin, Germany) - 1 Apr 2015
Jamshidi Farzad, Nielsen Torsten O, Huntsman David G
Abstract excerpt
Rare conditions are sometimes ignored in biomedical research because of difficulties in obtaining specimens and limited interest from fund raisers. However, the study of rare diseases such as unusual cancers has again and again led to breakthroughs in our understanding of more common diseases. It is therefore unsurprising that with the development and accessibility of next-generation sequencing, much has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
